Search

Search Results

• Melanoma risk awareness and sun-protective behavior: Does the sun only hurt on the beach? A cross-sectional survey on 1288 families of a Mediterranean population

  Vincenzo De Giorgi, Aurora Gaeta, Federico Venturi, Elisabetta Magnaterra, Gian Marco Tomassini, Stefano Borgognoni, Biancamaria Zuccaro, Gabriella Perillo, Giovanni Cecchi, Federica Fazzari, Sara Gandini, Piero Covarelli

  03-03-2026

  https://doi.org/10.4081/dr.2026.10600

  374

  PDF: 301

• Successfully maintained complete remission of mycosis fungoides by umbilical cord blood transplantation: a case report and literature review

  Munenari Itoh, Sayaka Oshima, Hiroto Ishii, Shingo Yano, Akihiko Asahina, Yoshimasa Nobeyama

  07-04-2025

  https://doi.org/10.4081/dr.2025.10222

  541

  PDF: 338

  SUPPLEMENTARY MATERIAL: 55

  HTML: 18
• 

  12 | Integrated molecular and immunophenotypic profiling of uveal melanoma: prognostic insights and biological perspectives Francesco Fortarezza¹, Giovanni Zarrilli², Giada Munari¹, Valentina Angerilli³, Mariangela Balistreri¹, Luisa Piccin⁴, Valentina Salizzato⁴, Jacopo Pigozzo⁴, Giulia Midena⁵, Raffaele Parrozzani⁶, Valentina Guarneri^4|7, Edoardo Midena^5|6, Marta Sbaraglia^1|8, Matteo Fassan^8|9, Angelo Paolo Dei Tos^1|8 | ¹Surgical Pathology and Cytopathology Unit, Department of Integrated Diagnostics. Azienda Ospedale-Università Padova, Padua; ²Surgical Pathology Unit, Azienda Ulss 3 Serenissima, Ospedale dell'Angelo, Venezia; ³Department of Surgical Pathology, Azienda ULSS2 Marca Trevigiana, Treviso; ⁴Medical Oncology 2, Veneto Institute of Oncology, IOV-IRCCS, Padua; ⁵IRCCS-Fondazione Bietti, Rome; ⁶Department of Ophthalmology, University of Padova, Padova; ⁷Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua; ⁸Department of Medicine, University of Padua School of Medicine, Padua; ⁹Veneto Institute of Oncology, IOV-IRCCS, Padua, Italy.

  Italian Melanoma Intergroup

  11-12-2025

  https://doi.org/10.4081/dr.2025.10754

  410
• 

  36 | Neoadjuvant strategy for locally advanced conjunctival melanoma: a single-center approach to eye preservation F. Rifaldi^1|2, M. Angi³, L. Giuseppe¹, F. Lanza³, A. Spagnoletti¹, J. Sergenti³, A. Indini¹, E. Mastrogiuseppe³, M. Del Vecchio¹, L. Di Guardo¹ | ¹Melanoma Medical Oncology Unit, Department of Medical Oncology ed Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan; ²Fondazione IRCCS Policlinico San Matteo, Pavia; ³Ocular Oncology Service, Department of Surgical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

  Italian Melanoma Intergroup

  11-12-2025

  https://doi.org/10.4081/dr.2025.10778

  512
• 

  21 | Melanoma in situ: long-term outcomes and follow-up strategies based on risk stratification Beatrice De Checchi¹, Paolo del Fiore², Irene Russo², Chiara Trevisiol², Marco Domenico Mazza², Saveria Tropea², Francesco Russano², Mauro Alaibac³, Carlomaria Gianesini⁴, Giovanni Madeo⁴, Simone Mocellin^2|4 | ¹Department of Medicine, University of Padua, Padua; ²Soft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua; ³Department of Dermatology, University of Padua; ⁴Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.

  Italian Melanoma Intergroup

  11-12-2025

  https://doi.org/10.4081/dr.2025.10763

  462

• Melanoma in pregnancy: multidisciplinary treatment management and outcome

  Francesca Romana Grippaudo, Giulia Ruggeri, Paola De Simone, Monia Di Prete, Guglielmo Tellan, Elena Rita Govoni, Emilia Migliano

  15-01-2025

  https://doi.org/10.4081/dr.2025.10095

  552

  PDF: 324

  HTML: 24

• Neurocutaneous system: Is the skin a big eye with deep brain connections?

  Fortunato Cassalia, Andrea Danese, Paolo Del Fiore

  25-08-2026

  https://doi.org/10.4081/dr.2026.10930

  182

  PDF: 98
• 

  27 | Real-world data for malignant melanoma stage II adjuvant therapy Silvana Cozzolino¹, Antonino Colloca¹, Miriam Forte¹, Francesco Caraglia¹, Alfonso Esposito¹, Maria Cristina Giugliano¹, Eleonora Cioli¹, Marcella Scala², Maria Chiara Sergi³, Teresa Del Giudice⁴, Francesca Sparano⁵, Immacolata Paciolla⁶, Mariangela Pasqualoni⁷, Luigi Formisano², Stefania Napolitano¹, Antonio Maria Grimaldi¹, Paolo Antonio Ascierto⁵, Fortunato Ciardiello¹, Teresa Troiani¹, Vincenzo De Falco¹ | ¹Medical Oncology, Department of Precision Medicine, University of Campania "Luigi Vanvitelli", Naples; ²Department of Clinical Medicine and Surgery, University of Naples "Federico II", Naples, Italy; ³Division of Medical Oncology, "Mons. A.R. Dimiccoli" Hospital, Barletta; ⁴Nuclear Medicine Unit, "Mater Domini" University Hospital, Catanzaro; ⁵Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples; ⁶Medical Oncology Unit, AORN "San Pio", Benevento, Italy; ⁷Medical Oncology Unit, ASL Taranto, Italy.

  Italian Melanoma Intergroup

  11-12-2025

  https://doi.org/10.4081/dr.2025.10769

  445

• Real-world experience with vismodegib and sonidegib in advanced basal cell carcinoma: a multicenter Italian study

  Mario Valenti, Sara Di Giulio, Andrea Carugno, Pasquale Frascione, Angelo Valerio Marzano, Santo Raffaele Mercuri, Gianluca Nazzaro, Giulia Spallone, Giovanni Paolino, Marco Ardigò

  18-02-2025

  https://doi.org/10.4081/dr.2025.10196

  677

  PDF: 568

  HTML: 27

• Mendelian randomization analysis of the causal relationship between immune cells and keloid

  Jingwen Zou, Pengkhun Nov, Kunpeng Du

  23-10-2024

  https://doi.org/10.4081/dr.2024.10106

  886

  PDF: 463

  SUPPLEMENTARY MATERIAL: 164

  HTML: 23

• Focal facial dermal dysplasia type IV: a case series

  Laura Gnesotto, Mario Cutrone, Giuseppe Ruggiero, Carla Morando, Anna Belloni Fortina, Annalisa Patrizi, Luigi Naldi, Andrea Sechi

  15-04-2025

  https://doi.org/10.4081/dr.2025.10199

  641

  PDF: 331

  HTML: 45

• 46 | IS AJCC STAGE IIA MELANOMA A HOMOGENEOUS DISEASE? A 23-YEAR SINGLE-CENTER EXPERIENCE C. Cescatti¹, C. Trevisiol², P. Del Fiore², G. Madeo³, N. Romagnolo⁴, F. Cassalia², A. Acciardi², S. Mocellin^2|3, M. Alaibac⁴ | ¹Department of Medicine (DIMED), School of Medicine, University of Padova, Italy; ²Soft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Italy; ³Department of Surgery, Oncology and Gastroenterology (DISCOG), University of Padova, Italy; ⁴Dermatology Unit, Department of Medicine, University of Padova, Italy

  Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica

  24-09-2026

  https://doi.org/10.4081/dr.2026.11066

  79

  PDF: 27

• Dermatitis artefacta: a challenging diagnosis

  Giulia Ciccarese, Giorgia Salvia, Cristian Fidanzi, Mario Mastrolonardo, Francesco Drago

  29-11-2024

  https://doi.org/10.4081/dr.2024.10014

  986

  PDF: 286

  HTML: 38

• Erythema nodosum-like panniculitis during BRAF inhibitor therapy for melanoma: never forget latent tuberculosis infection

  Alba Guglielmo, Lorenzo D'Alì, Maria Ludovica Deotto, Alessia Cimadamore, Gaetano Pascoletti, Elena Poletto, Alessandro Minisini

  04-06-2026

  https://doi.org/10.4081/dr.2026.10380

  515

  PDF: 326

• Italian Melanoma Intergroup tele-genetic counseling project for melanoma predisposition syndromes: 5-year evaluation of effectiveness and outcomes

  Andrea Carugno, Emanuela Passoni, Giovanna Pogliaghi, Francesca Morgese, Elena Maccaroni, Paola Ghiorzo, Lorenza Pastorino, Bruna Dalmasso, William Bruno, Monica Barile

  03-09-2025

  https://doi.org/10.4081/dr.2025.10510

  358

  PDF: 259

  HTML: 15
• 

  04 | Association of a novel TERT polymorphism with poorer survival in male patients with melanoma Fortunato Cassalia¹, Maria Santa Rocca², Andrea Di Nisio³, Paolo del Fiore*⁴, Clara Benna^5|7, Ilaria Cosci⁶, Simone Mocellin^4|5, Alberto Ferlin*^2|6 | ¹Department of Dermatology, University of Padua, Padua; ²Unit of Andrology and Reproductive Medicine, University Hospital of Padua, Padua; ³Department of Wellbeing, Nutrition and Sport, Pegaso Telematic University, Naples; ⁴Soft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, Padua; ⁵Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua; ⁶Department of Medicine, University of Padua, Padua; ⁷Unit of Biostatistics, Epidemiology and Public Health, Department of Cardio-Thoraco-Vascular Sciences and Public Health, University of Padua, Padua, Italy.

  Italian Melanoma Intergroup

  11-12-2025

  https://doi.org/10.4081/dr.2025.10746

  437

• Omalizumab for treatment of refractory urticaria in a patient with metastatic uveal melanoma receiving tebentafusp

  Faith Simmonds, Veronica Kashua, Diana McDonnell, Mariam El-Ashmawy, Alexandra J. Coromilas

  06-05-2026

  https://doi.org/10.4081/dr.2026.10366

  388

  PDF: 328
• 

  Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

  Klaudia Miklusiak, Karol Miklusiak, Olga Kaczmarczyk, Dorota Cibor, Małgorzata Zwolińska-Wcisło

  22-05-2023

  https://doi.org/10.4081/dr.2023.9630

  1122

  PDF: 592

  HTML: 97

• 47 | RECURRENCE DEFINES PROGNOSIS IN THICK MELANOMA: A LONG-TERM SINGLE-CENTER EXPERIENCE S. Apa¹, P. Del Fiore², C. Trevisiol², G. Madeo³, N. Romagnolo⁴, F. Cassalia², A. Acciardi², S. Mocellin^2|3, M. Alaibac⁴ | ¹Department of Medicine (DIMED), School of Medicine, University of Padova, Italy; ²Soft-Tissue, Peritoneum and Melanoma Surgical Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Italy; ³Department of Surgery, Oncology and Gastroenterology (DISCOG), University of Padova, Italy; ⁴Dermatology Unit, Department of Medicine, University of Padova, Italy

  Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica

  24-09-2026

  https://doi.org/10.4081/dr.2026.11067

  78

  PDF: 27

• A large unilateral basal cell carcinoma treated with Hedgehog inhibitor sonidegib: a case report

  Maria Alessandra Mattioli, Valentina Benzecry, Giulia Murgia, Nerina Denaro, Angelo Valerio Marzano, Emanuela Passoni, Gianluca Nazzaro

  20-11-2024

  https://doi.org/10.4081/dr.2024.10152

  578

  PDF: 283

  HTML: 35
• 

  30 | Sonidegib for nevoid basal cell carcinoma (Gorlin) syndrome and EADO stage IIb sporadic basal cell carcinomas: a phase II study (SIBLINGS trial) Sara Farinatti^1|2, Giuseppe Agenziano³, Emi Dika^4|5, Emanuela Passoni⁶, Ketty Peris⁷, Pietro Quaglino⁸, Paola Queirolo⁹, Massimiliano Scalvenzi¹⁰, Iris Zalaudek¹¹, Luigi Lorini¹¹, Cristina Gurizzan¹, Monica Variolo^1|2, Paolo Bossi*^1|2, Carlo Resteghini*^1|2 | ¹Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milano; ²Department of Biomedical Sciences, Humanitas University, Rozzano ^MI; ³Unit of Dermatology, Luigi Vanvitelli University of Campania, Naples; ⁴Oncologic Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna; ⁵Department of Medical and Surgical Sciences, DIMEC, University of Bologna, Bologna; ⁶Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan; ⁷Institute of Dermatology, Catholic University of the Sacred Heart, Rome; Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome; ⁸Dermatologic Clinic, University of Turin Medical School, Turin; ⁹Medical Oncology Unit; ¹⁰Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples; ¹¹Department of Dermatology and Venereology, University of Trieste, Ospedale Maggiore, Trieste, Italy. *Contributed equally.

  Italian Melanoma Intergroup

  11-12-2025

  https://doi.org/10.4081/dr.2025.10772

  469

• Lichenoid dermatitis induced by abemaciclib in a patient with HR+/HER2– breast cancer

  Edoardo Mortato, Anna Paola De Caro, Luca Schinzari, Sonia Maniglio, Carmelo Laface, Gerardo Cazzato, Caterina Foti, Francesca Ambrogio

  19-11-2024

  https://doi.org/10.4081/dr.2024.10144

  715

  PDF: 426

  HTML: 47

• Unusual presentation of skin nodule in a child: a case report of primary cutaneous CD4⁺ small/medium T-cell lymphoproliferative disorder and literature review

  Lama Aloraifi, Hadeel Alotaibi, Sultan Bajawi, Nouf Bajawi, Amnah Almulhim, Lenah Shaikh

  09-05-2025

  https://doi.org/10.4081/dr.2025.10163

  553

  PDF: 347

  HTML: 49

• The use of dermal templates in dermato-surgery and patient perspectives

  Serena Morsia, Alessia Paganelli, Alessandra Acciardi, Antonio Alma, Cristina Bertoli, Camilla Reggiani, Federico Garbarino, Chiara Fiorentini, Barbara Ferrari, Mariangela Francomano, Cristina Magnoni

  15-02-2024

  https://doi.org/10.4081/dr.2024.9941

  775

  PDF: 662

  HTML: 45
• 

  28 | Efficacy and toxicity outcomes with doublet immunotherapy in metastatic melanoma: the real-world REALIPINIVO study Miriam Forte¹, Francesco Caraglia¹, Silvana Cozzolino¹, Antonino Colloca¹, Alfonso Esposito¹, Maria Cristina Giugliano¹, Eleonora Cioli¹, Marcella Scala², Francesca Sparano⁵, Maria Chiara Sergi³, Teresa Del Giudice⁴, Immacolata Paciolla⁶, Luigi Formisano², Stefania Napolitano¹, Antonio Maria Grimaldi⁶, Paolo Antonio Ascierto⁵, Fortunato Ciardiello¹, Teresa Troiani¹, Vincenzo De Falco¹ | ¹Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples; ²Department of Clinical Medicine and Surgery, Federico Il University, Naples; ³Unità Operativa Complessa di Oncologia Medica, Ospedale "Mons. A.R. Dimiccoli", Barletta; ⁴Nuclear Medicine Unit, "Mater Domini" University Hospital, Catanzaro; ⁵Istituto Nazionale Tumori IRCCS Fondazione Giovanni Pascale Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Napoli; ⁶Medical Oncology Unit AORN "San Pio", Benevento, Italy.

  Italian Melanoma Intergroup

  11-12-2025

  https://doi.org/10.4081/dr.2025.10770

  442